Literature DB >> 31209506

Degradome of soluble ADAM10 and ADAM17 metalloproteases.

Franka Scharfenberg1, Andreas Helbig2, Martin Sammel3, Julia Benzel4, Uwe Schlomann4, Florian Peters3, Rielana Wichert3, Maximilian Bettendorff3, Dirk Schmidt-Arras5, Stefan Rose-John5, Catherine Moali6, Stefan F Lichtenthaler7,8,9, Claus U Pietrzik10, Jörg W Bartsch4, Andreas Tholey2, Christoph Becker-Pauly11.   

Abstract

Disintegrin and metalloproteinases (ADAMs) 10 and 17 can release the extracellular part of a variety of membrane-bound proteins via ectodomain shedding important for many biological functions. So far, substrate identification focused exclusively on membrane-anchored ADAM10 and ADAM17. However, besides known shedding of ADAM10, we identified ADAM8 as a protease capable of releasing the ADAM17 ectodomain. Therefore, we investigated whether the soluble ectodomains of ADAM10/17 (sADAM10/17) exhibit an altered substrate spectrum compared to their membrane-bound counterparts. A mass spectrometry-based N-terminomics approach identified 134 protein cleavage events in total and 45 common substrates for sADAM10/17 within the secretome of murine cardiomyocytes. Analysis of these cleavage sites confirmed previously identified amino acid preferences. Further in vitro studies verified fibronectin, cystatin C, sN-cadherin, PCPE-1 as well as sAPP as direct substrates of sADAM10 and/or sADAM17. Overall, we present the first degradome study for sADAM10/17, thereby introducing a new mode of proteolytic activity within the protease web.

Entities:  

Keywords:  ADAM10; ADAM17; ADAM8; Ectodomain shedding; Proteolysis; TAILS

Mesh:

Substances:

Year:  2019        PMID: 31209506     DOI: 10.1007/s00018-019-03184-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  95 in total

Review 1.  The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions.

Authors:  Karina Reiss; Paul Saftig
Journal:  Semin Cell Dev Biol       Date:  2008-11-13       Impact factor: 7.727

Review 2.  The metalloproteinase ADAM10: A useful therapeutic target?

Authors:  Sebastian Wetzel; Lisa Seipold; Paul Saftig
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-06-15       Impact factor: 4.739

Review 3.  Ectodomain shedding and ADAMs in development.

Authors:  Silvio Weber; Paul Saftig
Journal:  Development       Date:  2012-10       Impact factor: 6.868

Review 4.  Who decides when to cleave an ectodomain?

Authors:  Monika Hartmann; Andreas Herrlich; Peter Herrlich
Journal:  Trends Biochem Sci       Date:  2013-01-05       Impact factor: 13.807

Review 5.  Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.

Authors:  Franka Scharfenberg; Fred Armbrust; Liana Marengo; Claus Pietrzik; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

6.  Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.

Authors:  Mourad Bekhouche; Daniel Kronenberg; Sandrine Vadon-Le Goff; Cécile Bijakowski; Ngee Han Lim; Bernard Font; Efrat Kessler; Alain Colige; Hideaki Nagase; Gillian Murphy; David J S Hulmes; Catherine Moali
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

7.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

8.  Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.

Authors:  Elena Marcello; Claudia Saraceno; Stefano Musardo; Hugo Vara; Alerie Guzman de la Fuente; Silvia Pelucchi; Daniele Di Marino; Barbara Borroni; Anna Tramontano; Isabel Pérez-Otaño; Alessandro Padovani; Maurizio Giustetto; Fabrizio Gardoni; Monica Di Luca
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

9.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  22 in total

Review 1.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

Review 2.  Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing.

Authors:  José J M Vitória; Diogo Trigo; Odete A B da Cruz E Silva
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

3.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

4.  Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State.

Authors:  Chun-Yao Yang; Simone Bonelli; Matteo Calligaris; Anna Paola Carreca; Stephan A Müller; Stefan F Lichtenthaler; Linda Troeberg; Simone D Scilabra
Journal:  Membranes (Basel)       Date:  2022-05-31

5.  Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage.

Authors:  Rielana Wichert; Franka Scharfenberg; Cynthia Colmorgen; Tomas Koudelka; Jeanette Schwarz; Sebastian Wetzel; Barbara Potempa; Jan Potempa; Jörg W Bartsch; Irit Sagi; Andreas Tholey; Paul Saftig; Stefan Rose-John; Christoph Becker-Pauly
Journal:  FASEB J       Date:  2019-08-09       Impact factor: 5.191

Review 6.  Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10.

Authors:  Dmitriy Minond
Journal:  Front Mol Biosci       Date:  2020-05-06

7.  Mutagenesis of the ADAM17-phosphatidylserine-binding motif leads to embryonic lethality in mice.

Authors:  Martin Veit; Björn Ahrens; Jana Seidel; Anselm Sommer; Sucharit Bhakdi; Karina Reiss
Journal:  Life Sci Alliance       Date:  2019-08-27

8.  Impairment of carbonic anhydrase IX ectodomain cleavage reinforces tumorigenic and metastatic phenotype of cancer cells.

Authors:  Ivana Kajanova; Miriam Zatovicova; Lenka Jelenska; Olga Sedlakova; Monika Barathova; Lucia Csaderova; Michaela Debreova; Lubomira Lukacikova; Katarina Grossmannova; Martina Labudova; Tereza Golias; Eliska Svastova; Andreas Ludwig; Petr Muller; Borivoj Vojtesek; Jaromir Pastorek; Silvia Pastorekova
Journal:  Br J Cancer       Date:  2020-03-25       Impact factor: 7.640

Review 9.  Modulation of Immune Responses by Platelet-Derived ADAM10.

Authors:  Stefanie Maurer; Hans-Georg Kopp; Helmut R Salih; Korbinian N Kropp
Journal:  Front Immunol       Date:  2020-02-05       Impact factor: 7.561

10.  The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases.

Authors:  James L J Coleman; Tony Ngo; Rhyll E Smythe; Andrew J Cleave; Nicole M Jones; Robert M Graham; Nicola J Smith
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.